Lauren subtypes of advanced gastric cancer influence survival and response to chemotherapy: real-world data from the AGAMENON National Cancer RegistryJavier Gállego, Ana Custodio, Juana María Cano et al.|British Journal of Cancer|2017Cited by 106
Nomogram-based prediction of survival in patients with advanced oesophagogastric adenocarcinoma receiving first-line chemotherapy: a multicenter prospective study in the era of trastuzumabJavier Gállego, Ana Custodio, Alberto Carmona‐Bayonas et al.|British Journal of Cancer|2017Cited by 49
Anthracycline-based triplets do not improve the efficacy of platinum-fluoropyrimidine doublets in first-line treatment of advanced gastric cancer: real-world data from the AGAMEMON National Cancer RegistryJavier Gállego, Alberto Carmona‐Bayonas, Paula Jiménez‐Fonseca et al.|Gastric Cancer|2017Cited by 20